VYNE Therapeutics, Inc. (VYNE)
0.6101
-0.01
(-2.35%)
USD |
NASDAQ |
Apr 14, 15:00
VYNE Therapeutics EPS Diluted (Quarterly) : -0.1452 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Apellis Pharmaceuticals, Inc. | -0.4654 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.96M |
| Revenue (Quarterly) | 0.13M |
| Total Expenses (Quarterly) | 5.09M |
| Enterprise Value | -8.188M |
| Gross Profit Margin (Quarterly) | 96.15% |
| Profit Margin (Quarterly) | -3.82K% |
| Earnings Yield | -106.8% |
| Normalized Earnings Yield | -106.80 |